Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	8.34	120.49	111.21
Graham Fair Price	41.34	1.23	0.87
PEG	-75.66	-0.02	0.08
Price/Book	0.06	0.28	0.28
Price/Cash Flow	83.97	-8.07	-50.36
Prices/Earnings	49.97	-1.90	-3.81
Price/Sales	-49.97	0.22	0.43
Price/FCF	83.97	-8.07	-50.36
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.14	0.14
Operating Margin	-552.80	-0.01	< 0.005
ROA	-100.00	-0.02	< 0.005
ROE	-0.02	-0.04	-100.00
ROIC	< 0.005	-0.01	-1198.16
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.01	-0.06	-75.06
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.96	-12.06	1157.61
EPS QOQ	0.48	-1.00	105.56
FCF QOQ	-0.02	-5.24	-30433.13
Revenue QOQ	-0.40	1.00	150.77
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	82.08	41.04	-50.00
Days Sales Outstanding (DSO)	65.17	34.75	-46.68
Inventory Turnover	1.10	2.19	100.00
Debt/Capitalization	0.40	0.40	0.86
Quick Ratio	0.77	0.88	15.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	1.34	1.34	-0.06
Cash	0.30	0.40	32.64
Capex	< 0.005	-0.02	-99.88
Free Cash Flow	< 0.005	-0.05	-523.94
Revenue	0.88	1.76	99.88
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.50	1.50	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	67.90	69.02	1.66
Naive Interpretation	Member

06 - Financial Health · Weak

Rating